‘‘(aa) the quantity of drugs sold or 
distributed per dosage form; 
‘‘(bb) the percentage of drugs sold or 
distributed with labeled indications that 
fall within each of the following categories: 
growth promotion, feed efficiency, or other 
production purposes; disease prevention; 
disease control; and disease treatment; 
‘‘(cc) the quantity of drugs sold or 
distributed per each of the following mar-
keting categories: over-the-counter, pre-
scription, and veterinary feed directive; and 
‘‘(dd) the quantity of drugs sold or 
distributed per State of sale or distribu-
tion. 
‘‘(iv) In carrying out this subparagraph, the 
Secretary shall report data in a manner consistent 
with protecting both national security and confiden-
tial business information. 
‘‘(E) In this paragraph, the terms ‘live poultry 
dealer’ and ‘swine contractor’ have the meanings 
given to those terms in section 2 of the Packers and 
Stockyards Act, 1921.’’. 
(b) RULE OF APPLICATION.—The amendment made 
by this section applies to reports under paragraphs (3) 
VerDate Mar 15 2010 
00:36 Mar 01, 2013
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H820.IH
H820
jbell on DSK7SPTVN1PROD with BILLS
and (4) of section 512(l) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360b(l)) (as amended by sub-
section (a)) that cover the period of calendar year 2014 
or any subsequent calendar year. The provisions of section 
512(l)(3) of such Act, as in effect the day before the date 
of enactment of this Act, apply to reports that cover the 
period of calendar year 2013. 
SEC. 5. ENHANCED COLLABORATION BETWEEN THE FOOD 
AND DRUG ADMINISTRATION AND THE DE-
PARTMENT OF AGRICULTURE. 
The Secretary of Health and Human Services, acting 
through the Commissioner of Food and Drugs, shall in-
crease collaboration and coordination with the Secretary 
of Agriculture to expand and coordinate the collection of 
data on the use of antimicrobial drugs in or on cattle, 
swine, chickens, turkeys, and such other food-producing 
animal species as agreed to by the Secretary of Health 
and Human Services and the Secretary of Agriculture, in-
cluding by providing information to the Secretary of Agri-
culture for use by— 
(1) the Animal and Plant Health Inspection 
Service to help inform its collection of data through 
the National Animal Health Monitoring System; and 
VerDate Mar 15 2010 
00:36 Mar 01, 2013
Jkt 029200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H820.IH
H820
jbell on DSK7SPTVN1PROD with BILLS
(2) the Economic Research Service to help in-
form its collection of data through the Agricultural 
Resource Management Survey. 
SEC. 6. ACTION BY GOVERNMENT ACCOUNTABILITY OF-
FICE. 
(a) PUBLICATION OF FINAL GUIDANCE.—Not later 
than 180 days after the date of enactment of this Act, 
the Secretary of Health and Human Services shall publish 
a final version of draft guidance #213, entitled ‘‘New Ani-
mal Drugs and New Animal Drug Combination Products 
Administered in or on Medicated Feed or Drinking Water 
of Food-Producing Animals: Recommendations for Drug 
Sponsors for Voluntarily Aligning Product Use Conditions 
with GFI #209’’. 
(b) REPORT BY GAO.— 
(1) IN GENERAL.—Not later than 3 years after 
the publication of final guidance pursuant to sub-
section (a), the Comptroller General of the United 
States shall commence a study to evaluate— 
(A) the voluntary approach used by the 
Food and Drug Administration to eliminate in-
judicious use of antimicrobial drugs in food-pro-
ducing animals; and 
VerDate Mar 15 2010 
00:36 Mar 01, 2013
Jkt 029200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H820.IH
H820
jbell on DSK7SPTVN1PROD with BILLS
(B) the effectiveness of the data collection 
activities conducted by the Food and Drug Ad-
ministration regarding antimicrobial resistance. 
(2) REPORT.—Not later than 1 year after com-
mencing the study required by paragraph (1), the 
Comptroller General of the United States shall sub-
mit to the Committee on Health, Education, Labor, 
and Pensions of the Senate and the Committee on 
Energy and Commerce of the House of Representa-
tives a report that describes the results of such 
study. 
Æ 
VerDate Mar 15 2010 
00:36 Mar 01, 2013
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6301
E:\BILLS\H820.IH
H820
jbell on DSK7SPTVN1PROD with BILLS